MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 44 filers reported holding MERUS N V in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $711,000 | -15.4% | 34,021 | -29.0% | 0.02% | -15.8% |
Q4 2020 | $840,000 | +55.8% | 47,908 | +6.7% | 0.02% | -5.0% |
Q3 2020 | $539,000 | -28.7% | 44,908 | -4.4% | 0.02% | -47.4% |
Q2 2020 | $756,000 | +53.0% | 46,978 | +15.1% | 0.04% | +18.8% |
Q1 2020 | $494,000 | -20.1% | 40,822 | -7.0% | 0.03% | +14.3% |
Q4 2019 | $618,000 | -41.2% | 43,911 | -25.6% | 0.03% | -58.8% |
Q3 2019 | $1,051,000 | +214.7% | 58,985 | +158.9% | 0.07% | +58.1% |
Q2 2019 | $334,000 | – | 22,785 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |